IART Integra LifeSciences Holdings Corporation

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

Integra LifeSciences Announces Participation in Upcoming Investor Conferences

PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

  • On September 9, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Wells Fargo 2021 Virtual Healthcare Conference at 11:20am ET.
  • On September 13, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley 19th Annual Global Healthcare Conference at 1:15pm ET.

Webcast information can be found on the Company’s website at .

About Integra LifeSciences

Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, MatriStem® UBM, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit .

Investor Relations:

Michael Beaulieu

(609) 529-4812

  

Media Contact:

Laurene Isip

(609) 208-8121



EN
02/09/2021

Underlying

IARTIntegra LifeSciences Holdings Corporation

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Integra LifeSciences Holdings Corporation

 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host Third Quarter 2025 Financial Results Conf...

Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: IART), a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dia...

October 15, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at t...

Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IART), a leading global medical technology company, is pleased to announce its exhibition at the CNS Annual Meeting, from October 11 through 15, 2025, in Los Angeles, California. The company’s booth will spotlight its industry-leading products, while featuring two recent additions to the portfolio - and . Durepair Dura...

October 8, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Leadership to Present at Wells Fargo and Morgan S...

Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare conferences: Wells Fargo Healthcare Conference on September 3, 2025, at 12:45 p.m. ETMorgan Stanley Healthcare Conference on September 10, 2025, at 8:30 a.m. ET A live webcast of the pr...

August 29, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences Reports Second Quarter 2025 Financial Results

Integra LifeSciences Reports Second Quarter 2025 Financial Results PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2025. Second Quarter 2025 Highlights Second quarter revenues exceeded guidance; adjusted earnings per diluted share (EPS) at the top end of the rangeSecond quarter revenues of $415.6 million decreased (0.6)% on a reported basis and (1.4)% on an organic basis compared to the prior year.Second quarter GAAP earnings per diluted share of $...

July 31, 2025 1 EN
 PRESS RELEASE
Free
IART Integra LifeSci...

Integra LifeSciences to Host Second Quarter 2025 Financial Results Con...

Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) --  (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at . For those planning to participate on the call, register  to receive dial-in...

July 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch